Compare Seed Co., Ltd. /7743/ with Similar Stocks
Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 0.89% and Operating profit at 4.55% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Capital Employed (avg) of 4.68% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 0.89% and Operating profit at 4.55% over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
Stock DNA
Pharmaceuticals & Biotechnology
JPY 18,674 Million (Small Cap)
12.00
NA
0.00%
0.77
7.26%
1.01
Revenue and Profits:
Net Sales:
8,380 Million
(Quarterly Results - Dec 2025)
Net Profit:
74 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.86%
0%
3.86%
6 Months
7.83%
0%
7.83%
1 Year
14.29%
0%
14.29%
2 Years
-9.2%
0%
-9.2%
3 Years
5.34%
0%
5.34%
4 Years
22.06%
0%
22.06%
5 Years
-4.98%
0%
-4.98%
Seed Co., Ltd. /7743/ for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.89%
EBIT Growth (5y)
4.55%
EBIT to Interest (avg)
6.33
Debt to EBITDA (avg)
3.38
Net Debt to Equity (avg)
0.77
Sales to Capital Employed (avg)
0.91
Tax Ratio
17.04%
Dividend Payout Ratio
41.56%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.68%
ROE (avg)
8.65%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.74
EV to EBIT
17.45
EV to EBITDA
5.51
EV to Capital Employed
0.85
EV to Sales
0.82
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
4.90%
ROE (Latest)
6.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
8,379.70
8,596.30
-2.52%
Operating Profit (PBDIT) excl Other Income
987.20
1,298.80
-23.99%
Interest
95.70
94.00
1.81%
Exceptional Items
0.20
56.90
-99.65%
Consolidate Net Profit
74.30
452.20
-83.57%
Operating Profit Margin (Excl OI)
19.40%
58.30%
-3.89%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -2.52% vs 0.57% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -83.57% vs 18.04% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
33,231.60
32,396.80
2.58%
Operating Profit (PBDIT) excl Other Income
4,947.00
4,880.50
1.36%
Interest
337.50
213.40
58.15%
Exceptional Items
-8.70
-30.30
71.29%
Consolidate Net Profit
1,100.50
1,963.50
-43.95%
Operating Profit Margin (Excl OI)
47.00%
63.30%
-1.63%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 2.58% vs 5.89% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -43.95% vs 656.39% in Mar 2024
About Seed Co., Ltd. /7743/ 
Seed Co., Ltd. /7743/
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






